Merck to buy EyeBio, maker of eye drug, as it grows pipeline

AdobeLONDON—MercksaidWednesdayitisbuyingophthalmology-focusedstartupEyeBioinadealworthupto$3billion, SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We




fashion

author：Wikipedia    Page View：7421
Two Vertex buidings in the Seaport District
David L Ryan/Globe Staff

When Vertex Pharmaceuticals moved from Cambridge to Boston’s Seaport a decade ago, it signaled that what was then a sea of parking lots could be a booming business district, and galvanized a wave of new development.

Now, Vertex may be on the move again.

advertisement

With the lease on its two-building campus on Fan Pier set to expire in 2028, the company is reevaluating its real estate options — and considering leaving its prominent headquarters for another spot in the neighborhood.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In
Previous article： Childbirth
Next article： Hepatitis C has a cure — but many Americans still lack access to it